| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/23/1992 | EP0504862A1 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of C3-7 alpha-hydroxy carboxylic acid |
| 09/23/1992 | EP0504807A1 Use of bis-(p-hydroxyphenylthio)methane derivatives to inhibit progressive development of insulin-dependent diabetes mellitus |
| 09/23/1992 | EP0504799A1 Mixted pyridine-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation, their use as well as medicaments based on these compounds |
| 09/23/1992 | EP0504695A1 New carboxamides, their preparation and pharmaceutical compositions containing them |
| 09/23/1992 | EP0504680A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
| 09/23/1992 | EP0504679A1 New imidazopyridines as serotonergic 5-HT3 antagonists |
| 09/23/1992 | EP0504645A2 Use of sulphated oligosaccharides for the treatment of arteriosclerotic diseases and for the prevention of restenosis |
| 09/23/1992 | EP0504574A1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same |
| 09/23/1992 | EP0504403A1 Topical therapeutic preparation |
| 09/23/1992 | EP0504290A1 Inhibitors of pneumocystis carinii dihydrofolate reductase. |
| 09/23/1992 | EP0504289A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product |
| 09/23/1992 | EP0504236A1 Utilisation of extracts of algae for the preparation of pharmaceutical, cosmetic, food or agricultural compositions. |
| 09/23/1992 | EP0504216A1 Cephalosporins, processes for their preparation, intermediates and pharmaceutical compositions containing them |
| 09/23/1992 | EP0504186A1 Thiarubrine antifungal and antibiotic agents |
| 09/23/1992 | EP0504184A1 Active agent against retrovirus group viruses, compositions containing same and their use. |
| 09/23/1992 | EP0504180A1 Glycyl-p-amino-pyridine for the treatment of senile dementia states. |
| 09/23/1992 | EP0226591B1 Anti-tumor compositions containing the reaction product of a cytotoxic aldehyde with penicillamine and their use for the manufacture of medicaments |
| 09/23/1992 | CN1064701A Peroxyacid bleach precursor compositions |
| 09/23/1992 | CN1064682A Heterocyclic compounds |
| 09/23/1992 | CN1064679A 醌类衍生物 Quinone derivatives |
| 09/23/1992 | CN1064617A Dispensation of medicine for therapy of acute. chronica otitis media |
| 09/23/1992 | CA2106868A1 Compounds for use in the treatment of cancer |
| 09/23/1992 | CA2063494A1 Angiotensin ii antagonists incorporating a substituted imidazo (1,2-b)(1,2,4) triazole |
| 09/23/1992 | CA2060569A1 1,2,4-oxadiazole derivatives having monoamine oxidase b enzyme-inhibitory activity and method for preparing same |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | WO1992016544A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it |
| 09/22/1992 | WO1992016235A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | USRE34075 Dermal uses of trans-retinoids for the treatment of cancer |
| 09/22/1992 | US5149879 Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 09/22/1992 | US5149865 New p-oxibenzoic acid derivatives, process for their preparation and their use as drug |
| 09/22/1992 | US5149860 Carbamate derivatives |
| 09/22/1992 | US5149846 Deuterated analogs of 1,25-dihydroxycholecalciferol |
| 09/22/1992 | US5149832 Anthelmintic, insecticide, ectoparasicide, nematocide and acaricide |
| 09/22/1992 | US5149820 Anticarcinogenic or analgesic agent |
| 09/22/1992 | US5149815 N-substituted-2-aminoquinolines |
| 09/22/1992 | US5149804 Ecteinascidins 736 and 722 |
| 09/22/1992 | US5149801 Carboranes, anticarcinogenic agents, boron neutron capture therapy |
| 09/22/1992 | US5149718 Biological fluid purification system |
| 09/22/1992 | US5149714 Phenoxy indanamines for psychological disorders |
| 09/22/1992 | US5149713 4-amino-3-(4-chlorophenyl)-butyric acid |
| 09/22/1992 | US5149712 Topically applying nontoxic sodium and/or meglumine salts of diatrizoic acid |
| 09/22/1992 | US5149711 2-cyclopentenone derivatives |
| 09/22/1992 | US5149710 Pharmaceutical compositions for treating psoriasis |
| 09/22/1992 | US5149707 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole useful as antifungal agent |
| 09/22/1992 | US5149705 Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
| 09/22/1992 | US5149699 Treating hypertension and congestive heart failure |
| 09/22/1992 | US5149697 Controlling obesity |
| 09/22/1992 | US5149696 Antiestrogens |
| 09/22/1992 | US5149695 Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same |
| 09/22/1992 | US5149694 Combination of tobramycin and dexamethasone for topical ophthalmic use |
| 09/22/1992 | US5149693 Antiinflammatory agent and antibiotic |
| 09/22/1992 | US5149691 Applying to dental tissue; synergistic |
| 09/22/1992 | US5149688 Administering effective amounts of methotrexate and succinylacetone, a seven carbon ketoacid; for rheumatoid arthritis; autoimmune diseases |
| 09/22/1992 | US5149543 Ionically cross-linked polymeric microcapsules |
| 09/22/1992 | US5149542 Coating membrane and compositions prepared therefrom |
| 09/22/1992 | US5149538 Misuse-resistive transdermal opioid dosage form |
| 09/22/1992 | US5149537 Suppository form; reducing calcium levels in blood; taurocholic acid as enhancer for calcitonin |
| 09/22/1992 | US5149523 Polystyrenesulfonate-drug complex and solid dosage forms thereof |
| 09/22/1992 | US5149321 Brain resuscitation device and method for performing the same |
| 09/22/1992 | CA2105378A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | CA2102689A1 Novel caffeic acid derivative, oraposide, and cosmetic or pharmaceutic, especially dermatological, composition containing it |
| 09/22/1992 | CA2061662A1 Novel carboxylic amides |
| 09/22/1992 | CA1307793C Aralkyl esters and processes for their preparation |
| 09/22/1992 | CA1307791C2 -6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta [1,2-b]pyridine compounds |
| 09/22/1992 | CA1307790C Ethers |
| 09/22/1992 | CA1307788C 1,2,3,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo¬2,3-b|indoles, a process for their preparation and their use as medicaments |
| 09/22/1992 | CA1307787C Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors |
| 09/22/1992 | CA1307785C Oligosaccharide derivatives |
| 09/22/1992 | CA1307741C Use of alpha-21 selective adrenergic receptor agonists in memory enhancement |
| 09/22/1992 | CA1307740C Pharmaceutical preparation and method for inhibiting replication of htlv-iii (aids) virus |
| 09/22/1992 | CA1307739C Anti-inflammatory compositions |
| 09/21/1992 | CA2063185A1 Benzo-fused lactams that promote the release of growth hormone |
| 09/21/1992 | CA2062886A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 09/21/1992 | CA2062885A1 Substituted azetidinones as anti-inflammatory and anti-degenerative agents |
| 09/20/1992 | WO1992016512A1 Anti-cancer compounds |
| 09/20/1992 | WO1992016506A1 Isoindoles having cardiovascular activity |
| 09/20/1992 | WO1992016236A1 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| 09/20/1992 | CA2106583A1 Anti-cancer compounds |
| 09/20/1992 | CA2106483A1 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| 09/20/1992 | CA2105684A1 Isoindoles having cardiovascular activity |
| 09/20/1992 | CA2063369A1 Selective phenylation of 5-hydroxy-beta-carboline derivatives |
| 09/20/1992 | CA2063122A1 Imidazole derivatives bearing acidic functional groups as angiotensin ii antagonists |
| 09/19/1992 | WO1992016197A1 Composition and method containing optically pure (s) metoprolol |
| 09/19/1992 | WO1992016106A1 Control of sea lice in seawater fish |
| 09/19/1992 | CA2106494A1 Composition and method containing optically pure (s) metoprolol |
| 09/19/1992 | CA2063230A1 Cholesterol lowering agents |
| 09/19/1992 | CA2063177A1 Mixed pyridine-2,4- and -2,5-dicarboxamides, a process for preparing them, the use thereof and pharmaceuticals based on these compounds |
| 09/17/1992 | WO1992015693A1 Chimeric tar enzyme construction for hiv therapy |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015607A2 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/17/1992 | WO1992015604A1 Anti-testosterone compounds and method of use thereof |
| 09/17/1992 | WO1992015599A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS |
| 09/17/1992 | WO1992015592A1 TETRAHYDROTHIENO(2,3-c)PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION |
| 09/17/1992 | WO1992015588A1 Esters of antibacterial condensed carbapeneme derivatives |
| 09/17/1992 | WO1992015583A1 Imidazoacridines and their antineoplastic use |
| 09/17/1992 | WO1992015582A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES |
| 09/17/1992 | WO1992015574A1 Novel quinolones, process for their preparation and pharmaceutical compositions containing same |
| 09/17/1992 | WO1992015567A1 Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor |
| 09/17/1992 | WO1992015566A1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents |
| 09/17/1992 | WO1992015565A1 Nmda antagonists |